Search research articles
Contact Us
Filters
Showing results (141-150 of 173) with videos related to
Page
of 18
Sort By:
Practical Radiation Oncology
|
July 30, 2025
Volumetric Changes and Acute Toxicity with <sup>68</sup>Ga Prostate-Specific Membrane Antigen vs <sup>18</sup>F-Fluciclovine PET/CT Guided Post-Prostatectomy Radiation: Final Analysis of a Randomized Trial
Vishal R Dhere, David M Schuster, Subir Goyal, et al.
Clinical Nuclear Medicine
|
December 5, 2022
A Tale of 3 Tracers: Contrasting Uptake Patterns of 18F-Fluciclovine, 68Ga-PSMA, and 18F-FDG in the Uterus and Adnexa
Ismaheel O Lawal, Omotayo Atinuke Adediran, Saima Muzahir, et al.
Clinical Nuclear Medicine
|
February 2, 2023
A Discordant Pattern of Uptake on 68 Ga-PSMA PET/CT Versus 18 F-Fluciclovine PET/CT in Radiation-Induced Hepatitis : Implications for Early Postradiotherapy Imaging-Based Response Assessment
Omotayo A Adediran, Ismaheel O Lawal, Saima Muzahir, et al.
The Journal of Urology
|
October 23, 2013
Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial
David M Schuster, Peter T Nieh, Ashesh B Jani, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 7, 2018
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [<sup>18</sup>F]FDG: version 1.0
Ian Law, Nathalie L Albert, Javier Arbizu, et al.
Radiology
|
June 30, 2026
<sup>18</sup>F-Fluciclovine or <sup>68</sup>Ga-PSMA-11 PET/CT-guided Salvage Radiotherapy Changes in Postprostatectomy Biochemical Recurrence: Secondary Analysis of the EMPIRE-2 Trial
Olayinka A Abiodun-Ojo, Ashesh B Jani, Subir Goyal, et al.
Environmental Science & Technology
|
November 27, 2024
Dose-Related Mutagenic and Clastogenic Effects of Benzo[<i>b</i>]fluoranthene in Mouse Somatic Tissues Detected by Duplex Sequencing and the Micronucleus Assay
David M Schuster, Danielle P M LeBlanc, Gu Zhou, et al.
Annals of Surgical Oncology
|
March 20, 2015
Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach
Malcolm H Squires, N Volkan Adsay, David M Schuster, et al.
The Journal of Urology
|
October 18, 2016
Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (<sup>18</sup>F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer
Tore Bach-Gansmo, Cristina Nanni, Peter T Nieh, et al.
European Journal of Radiology
|
April 25, 2018
Prospective evaluation of fluciclovine (<sup>18</sup>F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients
Oladunni Akin-Akintayo, Funmilayo Tade, Pardeep Mittal, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 173) with videos related to
Sort By:
Page
of 18
Practical Radiation Oncology
|
July 30, 2025
Volumetric Changes and Acute Toxicity with <sup>68</sup>Ga Prostate-Specific Membrane Antigen vs <sup>18</sup>F-Fluciclovine PET/CT Guided Post-Prostatectomy Radiation: Final Analysis of a Randomized Trial
Vishal R Dhere, David M Schuster, Subir Goyal, et al.
Clinical Nuclear Medicine
|
December 5, 2022
A Tale of 3 Tracers: Contrasting Uptake Patterns of 18F-Fluciclovine, 68Ga-PSMA, and 18F-FDG in the Uterus and Adnexa
Ismaheel O Lawal, Omotayo Atinuke Adediran, Saima Muzahir, et al.
Clinical Nuclear Medicine
|
February 2, 2023
A Discordant Pattern of Uptake on 68 Ga-PSMA PET/CT Versus 18 F-Fluciclovine PET/CT in Radiation-Induced Hepatitis : Implications for Early Postradiotherapy Imaging-Based Response Assessment
Omotayo A Adediran, Ismaheel O Lawal, Saima Muzahir, et al.
The Journal of Urology
|
October 23, 2013
Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial
David M Schuster, Peter T Nieh, Ashesh B Jani, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 7, 2018
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [<sup>18</sup>F]FDG: version 1.0
Ian Law, Nathalie L Albert, Javier Arbizu, et al.
Radiology
|
June 30, 2026
<sup>18</sup>F-Fluciclovine or <sup>68</sup>Ga-PSMA-11 PET/CT-guided Salvage Radiotherapy Changes in Postprostatectomy Biochemical Recurrence: Secondary Analysis of the EMPIRE-2 Trial
Olayinka A Abiodun-Ojo, Ashesh B Jani, Subir Goyal, et al.
Environmental Science & Technology
|
November 27, 2024
Dose-Related Mutagenic and Clastogenic Effects of Benzo[<i>b</i>]fluoranthene in Mouse Somatic Tissues Detected by Duplex Sequencing and the Micronucleus Assay
David M Schuster, Danielle P M LeBlanc, Gu Zhou, et al.
Annals of Surgical Oncology
|
March 20, 2015
Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach
Malcolm H Squires, N Volkan Adsay, David M Schuster, et al.
The Journal of Urology
|
October 18, 2016
Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (<sup>18</sup>F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer
Tore Bach-Gansmo, Cristina Nanni, Peter T Nieh, et al.
European Journal of Radiology
|
April 25, 2018
Prospective evaluation of fluciclovine (<sup>18</sup>F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients
Oladunni Akin-Akintayo, Funmilayo Tade, Pardeep Mittal, et al.
Page
of 18